NCT03608046
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03608046 |
| Title | Avelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable Cancer (AVETUXIRI) |
| Acronym | AVETUXIRI |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Cliniques universitaires Saint-Luc- Universite Catholique de Louvain |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | BEL |
CKB BOOST